An American weight loss drug approved in a four-dose injection pen format for use in Britain could be available “within weeks”. Mounjaro, also known as tirzepatide, is a diabetes drug that was authorised by the Medicines and Healthcare products Regulatory Agency (MHRA) to help obese and overweight adults lose and manage weight in November last…

Continue Reading